http://www.fda.gov/cder/drug/infopage/paroxetine/default.htm
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
The FDA has issued a Public Health Advisory to alert physicians to reports of suicidal thinking (and suicide attempts) in clinical studies of various antidepressant drugs in pediatric patients with major depressive disorder (MDD).